Ariela Rivkah Orkaby, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 23 | 2024 | 2671 | 4.770 |
Why?
|
Frail Elderly | 24 | 2024 | 774 | 2.990 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2024 | 3253 | 2.920 |
Why?
|
Cardiovascular Diseases | 23 | 2024 | 15638 | 2.130 |
Why?
|
Primary Prevention | 7 | 2024 | 1189 | 2.130 |
Why?
|
Yoga | 3 | 2023 | 281 | 1.990 |
Why?
|
Geriatric Assessment | 19 | 2024 | 1422 | 1.960 |
Why?
|
Nails | 3 | 2021 | 298 | 1.210 |
Why?
|
Geriatrics | 6 | 2024 | 390 | 1.140 |
Why?
|
Aged | 84 | 2024 | 171514 | 1.080 |
Why?
|
Dementia | 5 | 2024 | 2724 | 0.880 |
Why?
|
Atherosclerosis | 4 | 2024 | 3431 | 0.880 |
Why?
|
Stroke | 7 | 2023 | 9790 | 0.830 |
Why?
|
Aspirin | 3 | 2024 | 3139 | 0.810 |
Why?
|
Advance Directives | 1 | 2024 | 249 | 0.800 |
Why?
|
Terminology as Topic | 3 | 2019 | 1539 | 0.790 |
Why?
|
Meditation | 1 | 2023 | 257 | 0.700 |
Why?
|
Postural Balance | 2 | 2021 | 638 | 0.690 |
Why?
|
Tai Ji | 1 | 2023 | 291 | 0.680 |
Why?
|
Myocardial Infarction | 7 | 2023 | 11515 | 0.650 |
Why?
|
Task Performance and Analysis | 1 | 2023 | 771 | 0.630 |
Why?
|
Hospitals, Veterans | 1 | 2021 | 395 | 0.620 |
Why?
|
Cholesterol | 5 | 2024 | 2910 | 0.610 |
Why?
|
Humans | 103 | 2024 | 768369 | 0.580 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2024 | 2279 | 0.580 |
Why?
|
Mobility Limitation | 1 | 2021 | 409 | 0.570 |
Why?
|
Hypercholesterolemia | 1 | 2024 | 1142 | 0.570 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2023 | 997 | 0.570 |
Why?
|
Independent Living | 2 | 2019 | 580 | 0.560 |
Why?
|
Aged, 80 and over | 31 | 2024 | 59679 | 0.550 |
Why?
|
Defibrillators, Implantable | 2 | 2024 | 1498 | 0.550 |
Why?
|
Pravastatin | 1 | 2018 | 393 | 0.540 |
Why?
|
International Classification of Diseases | 2 | 2021 | 925 | 0.520 |
Why?
|
Anticholesteremic Agents | 2 | 2024 | 972 | 0.510 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 220 | 0.510 |
Why?
|
Heart Arrest | 2 | 2023 | 1516 | 0.490 |
Why?
|
Heart Failure | 10 | 2024 | 11859 | 0.480 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2396 | 0.470 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 879 | 0.470 |
Why?
|
Accidental Falls | 2 | 2021 | 1081 | 0.460 |
Why?
|
Atrial Fibrillation | 4 | 2024 | 5162 | 0.450 |
Why?
|
Male | 53 | 2024 | 364761 | 0.450 |
Why?
|
Executive Function | 1 | 2023 | 1402 | 0.450 |
Why?
|
Physicians | 2 | 2022 | 4615 | 0.440 |
Why?
|
Carotid Stenosis | 1 | 2021 | 864 | 0.440 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1727 | 0.440 |
Why?
|
Risk Assessment | 12 | 2024 | 24310 | 0.430 |
Why?
|
Mortality | 3 | 2021 | 2917 | 0.430 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1398 | 0.420 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1395 | 0.410 |
Why?
|
Health Status Indicators | 1 | 2018 | 971 | 0.410 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2291 | 0.410 |
Why?
|
Risk Adjustment | 1 | 2016 | 603 | 0.390 |
Why?
|
Female | 47 | 2024 | 396926 | 0.370 |
Why?
|
Influenza, Human | 1 | 2022 | 1540 | 0.360 |
Why?
|
Coronary Disease | 3 | 2023 | 5926 | 0.360 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1408 | 0.350 |
Why?
|
Physical Examination | 3 | 2023 | 1262 | 0.350 |
Why?
|
Research | 1 | 2019 | 1984 | 0.350 |
Why?
|
Risk Factors | 20 | 2024 | 74915 | 0.340 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1134 | 0.340 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10358 | 0.340 |
Why?
|
Metformin | 1 | 2017 | 914 | 0.330 |
Why?
|
Cardiology | 1 | 2021 | 1701 | 0.330 |
Why?
|
United States | 24 | 2024 | 73120 | 0.330 |
Why?
|
Inflammation | 3 | 2024 | 10863 | 0.330 |
Why?
|
Life Style | 2 | 2018 | 3929 | 0.320 |
Why?
|
Retrospective Studies | 17 | 2024 | 81835 | 0.320 |
Why?
|
Exercise | 3 | 2023 | 5940 | 0.310 |
Why?
|
Aging | 4 | 2023 | 8762 | 0.300 |
Why?
|
Warfarin | 1 | 2016 | 1493 | 0.300 |
Why?
|
Memory | 1 | 2018 | 2210 | 0.300 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7449 | 0.270 |
Why?
|
Preoperative Care | 1 | 2016 | 2257 | 0.270 |
Why?
|
Prosthesis-Related Infections | 1 | 2012 | 491 | 0.270 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.260 |
Why?
|
United States Department of Veterans Affairs | 5 | 2024 | 937 | 0.250 |
Why?
|
Prospective Studies | 11 | 2024 | 54913 | 0.250 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3111 | 0.240 |
Why?
|
Age Factors | 5 | 2024 | 18477 | 0.230 |
Why?
|
Proportional Hazards Models | 5 | 2019 | 12561 | 0.220 |
Why?
|
Life Expectancy | 3 | 2021 | 1249 | 0.220 |
Why?
|
Sodium | 2 | 2019 | 1595 | 0.210 |
Why?
|
Institutionalization | 1 | 2023 | 108 | 0.210 |
Why?
|
Stroke Volume | 5 | 2023 | 5620 | 0.210 |
Why?
|
Trail Making Test | 1 | 2023 | 57 | 0.210 |
Why?
|
Internship and Residency | 2 | 2024 | 5952 | 0.210 |
Why?
|
England | 1 | 2024 | 533 | 0.200 |
Why?
|
Dementia, Vascular | 1 | 2023 | 125 | 0.200 |
Why?
|
State Medicine | 1 | 2024 | 217 | 0.200 |
Why?
|
Anticoagulants | 2 | 2021 | 4835 | 0.200 |
Why?
|
Middle Aged | 20 | 2024 | 223406 | 0.200 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2012 | 1418 | 0.190 |
Why?
|
Self Report | 2 | 2024 | 3771 | 0.190 |
Why?
|
Medicare | 6 | 2024 | 6880 | 0.180 |
Why?
|
Propensity Score | 2 | 2020 | 1970 | 0.180 |
Why?
|
Nutrition Assessment | 1 | 2024 | 740 | 0.180 |
Why?
|
Time Factors | 7 | 2021 | 40271 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3682 | 0.180 |
Why?
|
Pituitary-Adrenal System | 1 | 2023 | 557 | 0.170 |
Why?
|
Adult Children | 1 | 2020 | 104 | 0.170 |
Why?
|
Hand Strength | 1 | 2023 | 465 | 0.170 |
Why?
|
Hypolipidemic Agents | 1 | 2024 | 609 | 0.170 |
Why?
|
Cohort Studies | 8 | 2023 | 41782 | 0.170 |
Why?
|
Health Status | 3 | 2021 | 4096 | 0.170 |
Why?
|
Ventricular Function, Left | 4 | 2023 | 3941 | 0.170 |
Why?
|
Skilled Nursing Facilities | 1 | 2024 | 406 | 0.170 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2023 | 705 | 0.160 |
Why?
|
Coronary Artery Bypass | 3 | 2023 | 2194 | 0.160 |
Why?
|
Teaching Rounds | 1 | 2023 | 280 | 0.160 |
Why?
|
Hospitals | 2 | 2023 | 3906 | 0.160 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 2031 | 0.160 |
Why?
|
Rehabilitation Centers | 1 | 2020 | 250 | 0.160 |
Why?
|
Veterans Health | 1 | 2020 | 215 | 0.150 |
Why?
|
Drug Monitoring | 1 | 2024 | 964 | 0.150 |
Why?
|
Dietary Supplements | 2 | 2022 | 3445 | 0.150 |
Why?
|
Acetaminophen | 1 | 2022 | 556 | 0.150 |
Why?
|
Feasibility Studies | 3 | 2023 | 5308 | 0.150 |
Why?
|
Secondary Prevention | 1 | 2024 | 1479 | 0.150 |
Why?
|
Rehabilitation | 1 | 2019 | 131 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2023 | 1021 | 0.150 |
Why?
|
Malnutrition | 1 | 2024 | 632 | 0.140 |
Why?
|
Cholecalciferol | 1 | 2022 | 557 | 0.140 |
Why?
|
Hospital Mortality | 2 | 2022 | 5371 | 0.140 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2433 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14766 | 0.140 |
Why?
|
Comorbidity | 3 | 2023 | 10601 | 0.140 |
Why?
|
Health Services for the Aged | 1 | 2019 | 258 | 0.140 |
Why?
|
Foot | 1 | 2020 | 577 | 0.130 |
Why?
|
Nursing Homes | 1 | 2024 | 1084 | 0.130 |
Why?
|
Cognition | 3 | 2024 | 7062 | 0.130 |
Why?
|
Lipid Metabolism | 1 | 2024 | 1898 | 0.130 |
Why?
|
Hospice Care | 1 | 2022 | 679 | 0.130 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 941 | 0.120 |
Why?
|
Vitamins | 1 | 2022 | 1638 | 0.110 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1816 | 0.110 |
Why?
|
Electronic Health Records | 2 | 2024 | 4877 | 0.110 |
Why?
|
Prognosis | 6 | 2024 | 30031 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5887 | 0.110 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 829 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12242 | 0.110 |
Why?
|
Data Mining | 1 | 2018 | 561 | 0.110 |
Why?
|
Mentors | 1 | 2018 | 672 | 0.110 |
Why?
|
Cause of Death | 2 | 2022 | 3727 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 849 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 937 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2023 | 65408 | 0.100 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 681 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2018 | 773 | 0.100 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 747 | 0.100 |
Why?
|
Yogurt | 1 | 2012 | 71 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6549 | 0.100 |
Why?
|
Hospitalization | 5 | 2024 | 10845 | 0.100 |
Why?
|
Overweight | 1 | 2023 | 2428 | 0.100 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 417 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2017 | 2932 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2020 | 1509 | 0.100 |
Why?
|
Pilot Projects | 2 | 2024 | 8730 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2145 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1569 | 0.090 |
Why?
|
General Surgery | 1 | 2022 | 1714 | 0.090 |
Why?
|
Terminal Care | 1 | 2022 | 1773 | 0.090 |
Why?
|
Disease Progression | 2 | 2024 | 13643 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2023 | 3974 | 0.080 |
Why?
|
Incidence | 2 | 2024 | 21552 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5880 | 0.080 |
Why?
|
Quality Improvement | 2 | 2021 | 3858 | 0.080 |
Why?
|
Loneliness | 1 | 2011 | 207 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2020 | 15879 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10647 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3708 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 22286 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1439 | 0.060 |
Why?
|
Quality of Life | 2 | 2021 | 13497 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9687 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8372 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3267 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3961 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12875 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 9099 | 0.060 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2023 | 17 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26348 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3104 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13025 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39429 | 0.050 |
Why?
|
Adult | 5 | 2023 | 223528 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5508 | 0.040 |
Why?
|
Podiatry | 1 | 2020 | 28 | 0.040 |
Why?
|
Faculty | 1 | 2024 | 384 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8559 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 307 | 0.040 |
Why?
|
NAD | 1 | 2023 | 619 | 0.040 |
Why?
|
Knowledge Bases | 1 | 2019 | 97 | 0.040 |
Why?
|
Patient Discharge | 2 | 2022 | 3471 | 0.040 |
Why?
|
Needs Assessment | 1 | 2024 | 1146 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 783 | 0.040 |
Why?
|
Body Weight | 2 | 2023 | 4630 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8610 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1820 | 0.030 |
Why?
|
Absorbable Implants | 1 | 2019 | 339 | 0.030 |
Why?
|
Prevalence | 3 | 2021 | 15879 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 921 | 0.030 |
Why?
|
Nutritional Status | 1 | 2024 | 1623 | 0.030 |
Why?
|
Program Development | 1 | 2021 | 1296 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3412 | 0.030 |
Why?
|
Diuretics | 1 | 2018 | 612 | 0.030 |
Why?
|
Survivors | 1 | 2024 | 2379 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22389 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4040 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20232 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2226 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5367 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 8081 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1724 | 0.030 |
Why?
|
Sirolimus | 1 | 2019 | 1542 | 0.020 |
Why?
|
Lipids | 1 | 2023 | 3346 | 0.020 |
Why?
|
Polymers | 1 | 2019 | 1631 | 0.020 |
Why?
|
Aortic Valve | 1 | 2021 | 1967 | 0.020 |
Why?
|
Depression | 1 | 2011 | 8235 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1568 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7133 | 0.020 |
Why?
|
Group Practice | 1 | 2011 | 151 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2021 | 4526 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1751 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1197 | 0.020 |
Why?
|
Observation | 1 | 2011 | 311 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3629 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20763 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14725 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3644 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9642 | 0.020 |
Why?
|
Stents | 1 | 2019 | 3204 | 0.020 |
Why?
|
Primary Health Care | 1 | 2024 | 4736 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6521 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8537 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5151 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5103 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5043 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12450 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9379 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7955 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13065 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2696 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 3115 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8905 | 0.010 |
Why?
|
Heart Diseases | 1 | 2011 | 2816 | 0.010 |
Why?
|
Pain | 1 | 2011 | 5096 | 0.010 |
Why?
|